Similar articles

• [Determinants estimating cerebral functions after long term therapy with hydergin].

  Herzfeld U, Christian W, Ronge J, Wittgen M. Herzfeld U, et al. Arztl Forsch. 1972 Jun 10;26(6):215-28. Arztl Forsch. 1972. PMID: 4626216 Clinical Trial. German. No abstract available.
• Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.

  Meier-Ruge W, Emmenegger H, Enz A, Gygax P, Iwangoff P, Wiernsperger N. Meier-Ruge W, et al. Pharmacology. 1978;16 Suppl 1:45-62. doi: 10.1159/000136808. Pharmacology. 1978. PMID: 205890 No abstract available.
• Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.

  Loew DM, Jaton AL, Vigouret JM. Loew DM, et al. Postgrad Med J. 1976;52suppl 1:40-46. Postgrad Med J. 1976. PMID: 822407 No abstract available.
• [Wallerox increases cerebral circulation and heart capacity].

  Heynen U. Heynen U. Z Allgemeinmed. 1971 Dec 10;47(34):1823-5. Z Allgemeinmed. 1971. PMID: 5003212 Review. German. No abstract available.
• Morphological alterations of synaptic mitochondria during aging. The effect of Hydergine treatment.

  Bertoni-Freddari C, Fattoretti P, Casoli T, Spagna C, Meier-Ruge W. Bertoni-Freddari C, et al. Ann N Y Acad Sci. 1994 Jun 30;717:137-49. doi: 10.1111/j.1749-6632.1994.tb12081.x. Ann N Y Acad Sci. 1994. PMID: 8030830 Review. No abstract available.